Home/Filings/4/0001209191-23-002474
4//SEC Filing

MOLLOY ANTHONY 4

Accession 0001209191-23-002474

CIK 0001396814other

Filed

Jan 5, 7:00 PM ET

Accepted

Jan 6, 7:04 PM ET

Size

7.1 KB

Accession

0001209191-23-002474

Insider Transaction Report

Form 4
Period: 2023-01-04
MOLLOY ANTHONY
Chief Lgl & Compliance Officer
Transactions
  • Sale

    Common Stock

    2023-01-04$39.09/sh158$6,17719,996 total
  • Sale

    Common Stock

    2023-01-05$38.31/sh546$20,91719,450 total
Footnotes (3)
  • [F1]Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units.
  • [F2]Includes 204 shares of common stock acquired under the issuer's employee stock purchase plan in December 2022.
  • [F3]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.

Issuer

Pacira BioSciences, Inc.

CIK 0001396814

Entity typeother

Related Parties

1
  • filerCIK 0001900012

Filing Metadata

Form type
4
Filed
Jan 5, 7:00 PM ET
Accepted
Jan 6, 7:04 PM ET
Size
7.1 KB